| Radiotherapy - Adjuvant Versus Early Salvage (NCT00860652) | Trans Tasman Radiation Oncology Group | 2009-03-03 |
| Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer (NCT01006564) | Royal Marsden NHS Foundation Trust | 2009-03-01 |
| Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer (NCT00860158) | Noah Hahn, M.D. | 2009-03-01 |
| BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets (NCT00872157) | M.D. Anderson Cancer Center | 2009-03-01 |
| Test Semiquantitative Prostate Specific Antigen (PSA) (NCT00853710) | Institut Curie | 2009-03-01 |
| Exercise and Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion Therapy (NCT00856102) | University of Manitoba | 2009-03-01 |
| Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer (NCT00853697) | Memorial Sloan Kettering Cancer Center | 2009-03-01 |
| Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy (NCT00866554) | CHU de Quebec-Universite Laval | 2009-03-01 |
| Reduced Planning Target Volume (PTV) Margins for the Treatment of Prostate Cancer Using the Calypso 4D Localization System (NCT01589939) | U.S. Army Medical Research Acquisition Activity | 2009-03-01 |
| Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer (NCT00831623) | Loma Linda University | 2009-02-17 |
| Questionnaire and Fall Risk Assessment (NCT00836238) | M.D. Anderson Cancer Center | 2009-02-01 |
| A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy (NCT00719030) | Jonsson Comprehensive Cancer Center | 2009-02-01 |
| Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer (NCT00828308) | Brown University | 2009-02-01 |
| A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1 (NCT00852007) | Hamilton Health Sciences Corporation | 2009-02-01 |
| Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer (NCT01083771) | Brown University | 2009-02-01 |
| Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma (NCT00848601) | Astex Pharmaceuticals, Inc. | 2009-02-01 |
| Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer (NCT01220973) | Rutgers, The State University of New Jersey | 2009-02-01 |
| Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer (NCT00838201) | Amgen | 2009-02-01 |
| SonoVue Guided Prostate Biopsy (NCT00911027) | Bracco Diagnostics, Inc | 2009-02-01 |
| White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy (NCT00779168) | City of Hope Medical Center | 2009-01-29 |
| Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy (NCT00850941) | M.D. Anderson Cancer Center | 2009-01-26 |
| Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy (NCT01083368) | Case Comprehensive Cancer Center | 2009-01-01 |
| Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer (NCT00943956) | Institut du Cancer de Montpellier - Val d'Aurelle | 2009-01-01 |
| Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate (NCT00598858) | John P. Fruehauf | 2009-01-01 |
| Oncological and Functional Outcomes After Radical Prostatectomy for Prostate Cancer: Comparing Open With Robot-assisted Surgery (NCT01578356) | University Hospital, Ghent | 2009-01-01 |
| Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule (NCT02257827) | Gustavo Viani Arruda | 2009-01-01 |
| Safety Evaluation of ExAblate MRgFUS for Prostate Cancer (NCT00811265) | InSightec | 2009-01-01 |
| Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma (NCT00851682) | Washington University School of Medicine | 2009-01-01 |
| Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment (NCT01018901) | Abramson Cancer Center at Penn Medicine | 2009-01-01 |
| Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases (NCT00634582) | Wake Forest University Health Sciences | 2009-01-01 |
| A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme (NCT01752140) | Hospital de Santa Maria, Portugal | 2009-01-01 |
| Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. (NCT00757692) | British Columbia Cancer Agency | 2009-01-01 |
| Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer (NCT01414296) | Progenics Pharmaceuticals, Inc. | 2009-01-01 |
| Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation (NCT00805701) | Bay State Clinical Trials, Inc. | 2009-01-01 |
| Effect of Weight Loss on Prostate Cancer Pathology (NCT00475982) | VA Office of Research and Development | 2009-01-01 |
| BN83495 in Prostate Cancer (NCT00790374) | Ipsen | 2009-01-01 |
| Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer (NCT00814892) | Mayo Clinic | 2009-01-01 |
| Metabolomic Study for Localized Prostate Cancer (NCT01968538) | Georgetown University | 2009-01-01 |
| Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer (NCT00816452) | Sanofi | 2009-01-01 |
| Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer (NCT01087268) | Royal Marsden NHS Foundation Trust | 2009-01-01 |
| Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate (NCT00809991) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-12-22 |
| Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate (NCT00991315) | Rutgers, The State University of New Jersey | 2008-12-12 |
| PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment (NCT00694551) | H. Lee Moffitt Cancer Center and Research Institute | 2008-12-02 |
| S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases (NCT00874211) | SWOG Cancer Research Network | 2008-12-01 |
| Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer (NCT00814788) | University of California, Davis | 2008-12-01 |
| Evaluation Ultrasound Elasticity/Tissue Strain-Hardening Imaging for Prostate Cancer Patients Undergoing Radical Prostatectomy (NCT00824902) | M.D. Anderson Cancer Center | 2008-12-01 |
| Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer (NCT00685633) | Eastern Cooperative Oncology Group | 2008-12-01 |
| Multimodality Phase II Study in Prostate Cancer (NCT00734851) | Duke University | 2008-12-01 |
| Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer (NCT00786682) | University of Medicine and Dentistry of New Jersey | 2008-12-01 |
| Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer (NCT00801242) | Ferring Pharmaceuticals | 2008-12-01 |
| Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer (NCT00859729) | Uppsala University | 2008-12-01 |
| Intraprostatic MAXimal Simultaneous Boost (NCT00798837) | British Columbia Cancer Agency | 2008-12-01 |
| The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and Prostate (NCT00841685) | University Hospital, Ghent | 2008-12-01 |
| Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy (NCT00788307) | Mayo Clinic | 2008-11-03 |
| Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy (NCT00800813) | Memorial Sloan Kettering Cancer Center | 2008-11-01 |
| Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers (NCT00676286) | AHS Cancer Control Alberta | 2008-11-01 |
| A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer (NCT00808418) | Synta Pharmaceuticals Corp. | 2008-11-01 |
| B-Receptor Signaling in Cardiomyopathy (NCT01135849) | Daniel Bernstein | 2008-11-01 |
| Real Time Microscopic Imaging During Robot Assisted Prostate Cancer Surgery (NCT00792961) | Peter Delaney | 2008-11-01 |
| Transrectal Ultrasound Imaging of the Prostate Gland and Neurovascular Bundles During Robot-Assisted Laparoscopic Radical Prostatectomy (NCT00952666) | Johns Hopkins University | 2008-11-01 |
| The Physical Exercise and Prostate Cancer Study (NCT00658229) | Oslo University Hospital | 2008-11-01 |
| AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer (NCT00770848) | Amgen | 2008-11-01 |
| Study of Focal Cryoablation in Low-Risk Prostate Cancer (NCT00774436) | Memorial Sloan Kettering Cancer Center | 2008-10-14 |
| Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer (NCT00773773) | Memorial Sloan Kettering Cancer Center | 2008-10-14 |
| Exercise in Men With Prostate Cancer (NCT00834392) | University of Manitoba | 2008-10-01 |
| Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18) (NCT00967863) | UNICANCER | 2008-10-01 |
| Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer (NCT00769795) | University of Washington | 2008-10-01 |
| To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen (NCT00715078) | Dendreon | 2008-10-01 |
| A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer (NCT00958477) | Merck KGaA, Darmstadt, Germany | 2008-10-01 |
| Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance (NCT00796874) | Roswell Park Cancer Institute | 2008-10-01 |
| Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer (NCT00773305) | Summa Health System | 2008-10-01 |
| Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer (NCT00844792) | University Health Network, Toronto | 2008-10-01 |
| Radical Prostatectomy and Perioperative Fluid Therapy (NCT00771966) | Rigshospitalet, Denmark | 2008-10-01 |
| Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer (NCT01414283) | Progenics Pharmaceuticals, Inc. | 2008-10-01 |
| Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer (NCT00756392) | AHS Cancer Control Alberta | 2008-10-01 |
| Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients (NCT00895466) | Pepscan Therapeutics | 2008-10-01 |
| GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer (NCT01487720) | Asan Medical Center | 2008-10-01 |
| Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy (NCT00776594) | Dana-Farber Cancer Institute | 2008-10-01 |
| Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002) (NCT00777959) | Merck Sharp & Dohme LLC | 2008-10-01 |
| Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The James (NCT01643954) | Ohio State University Comprehensive Cancer Center | 2008-09-23 |
| Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer (NCT00924313) | National Cancer Institute (NCI) | 2008-09-10 |
| CMT-07-08: The PROstate Bed Evaluation Study (NCT00763152) | Varian, a Siemens Healthineers Company | 2008-09-01 |
| Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries (NCT00801996) | Weill Medical College of Cornell University | 2008-09-01 |
| Trans-Rectal Ultrasound-Guided (TRUS) Adverse Events (NCT00923416) | University Health Network, Toronto | 2008-09-01 |
| Study of WST11 in Patients With Localized Prostate Cancer (NCT00707356) | Steba Biotech S.A. | 2008-09-01 |
| A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer (NCT00670553) | Novartis Pharmaceuticals | 2008-09-01 |
| S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT00937417) | SWOG Cancer Research Network | 2008-09-01 |
| Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases (NCT00769990) | Masonic Cancer Center, University of Minnesota | 2008-09-01 |
| Vitamin D Effects on Prostate Pathology (NCT00741364) | University of Toronto | 2008-09-01 |
| Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer (NCT00882232) | Cancer Center of Irvine | 2008-09-01 |
| Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer (NCT00830635) | University of Colorado, Denver | 2008-09-01 |
| A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases (NCT00757757) | Novartis Pharmaceuticals | 2008-09-01 |
| Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer (NCT00924807) | Beth Israel Medical Center | 2008-09-01 |
| Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer (NCT00809458) | New Mexico Cancer Research Alliance | 2008-09-01 |
| Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients (NCT01401972) | Sunnybrook Health Sciences Centre | 2008-09-01 |
| Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer (NCT00967954) | Cancer Research UK | 2008-09-01 |
| A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030) (NCT00691899) | Merck Sharp & Dohme LLC | 2008-09-01 |
| Retrospective, Non-interventional Study of Depo-Eligard®. (NCT00811876) | Astellas Pharma Inc | 2008-09-01 |
| Validation of a Screening Tool in Geriatric Oncology (NCT00963911) | Institut Bergonié | 2008-08-05 |
| Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC) (NCT00751205) | Bayer | 2008-08-01 |